Phenycure Cream

What are the business opportunities for Phenylephrine 0.1% w/w + Beclometasone 0.025% w/w + Lidocaine 2.5% w/w Cream in the PCD pharma franchise market?

Phenylephrine 0.1% w/w + Beclometasone 0.025% w/w + Lidocaine 2.5% w/w Cream has consistent demand in the proctology, general surgery, gastroenterology, and primary healthcare segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on anorectal care and specialty healthcare portfolios.

Why should medical distributors include Phenylephrine 0.1% w/w + Beclometasone 0.025% w/w + Lidocaine 2.5% w/w Cream in their product range?

Medical distributors and agencies can benefit from consistent demand for symptomatic management of hemorrhoids and anorectal disorders under medical supervision. Phenylephrine 0.1% w/w is a vasoconstrictor that helps reduce swelling and congestion of hemorrhoidal blood vessels, providing relief from discomfort associated with piles Beclometasone 0.025% w/w is a corticosteroid that helps reduce inflammation, redness, swelling, and itching in the affected anorectal area Lidocaine 2.5% w/w is a local anesthetic that provides temporary relief from pain, burning, and irritation by numbing the affected area This combination is commonly prescribed for the symptomatic management of hemorrhoids (piles), anal fissures, proctitis, and other inflammatory anorectal conditions, as advised by healthcare professionals Topical cream formulation allows localized application, helping deliver the active ingredients directly to the affected area while minimizing systemic exposure Should be used only for the prescribed duration and under the supervision of a qualified healthcare professional. Patients should seek medical evaluation if symptoms persist, worsen, or are associated with significant rectal bleeding Frequently utilized in proctology clinics, gastroenterology practices, general surgery departments, hospitals, and community healthcare settings Widely prescribed by proctologists, gastroenterologists, general surgeons, and general physicians This strengthens a comprehensive anorectal care and gastrointestinal healthcare portfolio.

Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for this product?

Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Phenylephrine 0.1% w/w + Beclometasone 0.025% w/w + Lidocaine 2.5% w/w Cream with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.

What benefits do wholesalers get by partnering for this product?

Wholesalers and medical agencies benefit from consistent prescription demand, growing anorectal care market opportunities, reliable supply chain support, repeat purchases, and attractive margins in the specialty topical healthcare segment.

How can I become a distributor or franchise partner for this product?

Interested distributors, stockists, wholesalers, and institutional suppliers can partner with Cafoli LifeCare Pvt Ltd to access lucrative PCD pharma franchise opportunities across India. With exclusive monopoly rights, extensive promotional support, high-quality specialty healthcare products, attractive business margins, and dependable logistics support, Cafoli LifeCare Pvt Ltd helps franchise partners build a successful and profitable pharmaceutical business.